BSE · 542918
Gian Life Care Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1 Cr with net profit ₹0 Cr — a 10.71% net margin, versus -69.7% the period before.
Shareholding
As of 2026-03-31
- Promoter30.17%
- Public69.83%
4,243 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.81× from low to high.
Risk flags
Derived from disclosed data
- Promoter holding fell 1.93 percentage points to 30.17% in the latest disclosure.
Peer comparison
Healthcare · ranked #56 of 79 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,745 Cr | 243.18 | 13.58 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,614 Cr | 317.05 | 10.11 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹72,000 Cr | 270.94 | 7.28 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,671 Cr | 189.47 | 9.4 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,294 Cr | 300.11 | 9.24 | 8.48% | 8.36% |
| Global Health Limited | ₹38,529 Cr | 267.35 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,859 Cr | 751.13 | 14.17 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,566 Cr | 239.57 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,962 Cr | 255.88 | 5.46 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,554 Cr | 392.56 | 7.67 | 6.58% | 6.4% |
| Gian Life Care Limited(this company) | ₹5 Cr | — | 0.27 | -3.76% | -25.53% |
AI analysis
AI-generated · google/gemini-2.5-flashGian Life Care Limited is listed with a market capitalization of Rs 5 Cr. The company's book value per share is Rs 18.15. It has a reported return on equity of -375.51% and a return on capital employed of -1.017%. The debt-to-equity ratio stands at 0.28, and the profit margin is -25.53%.
Positives
- +The number of shareholders increased from 82 in September 2021 to 4243 in March 2026.
Negatives
- −The company has a negative return on equity (ROE) of -375.51%.
- −The return on capital employed (ROCE) is negative at -1.017%.
- −The company reported a negative profit margin of -25.53%.
- −Promoter holding has decreased from 60.7739% in September 2022 to 30.1662% in March 2026.
- −A significant portion of promoter shares, 65.08%, are pledged as of March 2026.
Financial Performance
For the period ending March 2025, the company reported revenue of Rs 1.11 Cr with a net loss of Rs 0.48 Cr. In the quarter ending June 2025, revenue was Rs 0.87 Cr with a net profit of Rs 0.05 Cr. In the latest quarter ending December 2025, revenue was Rs 1.12 Cr, and net profit was Rs 0.1 Cr.
Profitability & Returns
Gian Life Care Limited recorded a negative return on equity (ROE) of -375.51% and a negative return on capital employed (ROCE) of -1.017%. The company's profit margin is -25.53%. The latest reported EBITDA for the quarter ending December 2025 was Rs 0.22 Cr.
Balance Sheet
The company's debt-to-equity ratio is 0.28, indicating a moderate level of debt relative to equity. The book value per share is Rs 18.15. Further details on the balance sheet, such as assets and liabilities, are not available.
Ownership & Pledges
As of March 31, 2026, promoter holding in Gian Life Care Limited was 30.1662%. Public shareholding was 69.8338%. There were no shares held by DIIs or FIIs. A significant portion of promoter shares, 65.08%, are pledged. Specifically, Arun Kumar Gupta has pledged 2,030,157 shares, representing 67.7% of his promoter holding.
Shareholding History
Promoter holding has significantly decreased from 60.7739% in September 2022 to 30.1662% in March 2026. Conversely, public shareholding increased from 39.2261% to 69.8338% over the same period. The number of shareholders has increased from 496 in September 2022 to 4243 in March 2026.
Data as of — price: 2026-07-29 · financials: Dec 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.